Indemnification Clause May Be Stumbling Block For Daiichi Sankyo’s Arbitration Against Former Ranbaxy Owners
This article was originally published in PharmAsia News
Executive Summary
Neither Daiichi Sankyo nor former Ranbaxy owners would confirm arbitration procedures reportedly conducted in Singapore, but experts confirm the process has begun. A maze of complicated arguments is expected before a final verdict is out.